HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joyce S Plested Selected Research

Antibodies

12/2008Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures.
1/2004Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joyce S Plested Research Topics

Disease

12COVID-19
07/2023 - 12/2020
4Meningococcal Infections
12/2008 - 02/2002
2Infections
03/2024 - 01/2022
2Human Influenza (Influenza)
01/2022 - 01/2022
2Bacteremia
06/2009 - 04/2003
1Virus Diseases (Viral Diseases)
01/2024
1Myalgia
01/2022
1Pain (Aches)
01/2022
1Fatigue
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1Hypoxia (Hypoxemia)
01/2020
1Injection Site Reaction
01/2020

Drug/Important Bio-Agent (IBA)

16VaccinesIBA
07/2023 - 02/2002
7NVX-CoV2373 adjuvated lipid nanoparticleIBA
05/2023 - 12/2020
5Proteins (Proteins, Gene)FDA Link
07/2023 - 01/2020
4Immunoglobulin G (IgG)IBA
01/2024 - 12/2020
2COVID-19 VaccinesIBA
03/2024 - 01/2022
2Neutralizing AntibodiesIBA
01/2023 - 09/2022
2EpitopesIBA
12/2008 - 04/2003
2AntibodiesIBA
12/2008 - 01/2004
2LipopolysaccharidesIBA
12/2008 - 04/2003
1Messenger RNA (mRNA)IBA
01/2024
1Biomarkers (Surrogate Marker)IBA
02/2023
1Matrix-MIBA
01/2023
1Glycoproteins (Glycoprotein)IBA
01/2023
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2022
1NanovaccinesIBA
01/2022
1Saline SolutionIBA
01/2022
1VS 215IBA
01/2022
1Recombinant ProteinsIBA
06/2009
1Immunodominant EpitopesIBA
02/2002

Therapy/Procedure

1Contraindications
01/2022
1Intramuscular Injections
01/2022